Vaginal Fungal Infections Treatment Market
According to Intent Market Research, the Vaginal Fungi Infections Treatment Market is expected to grow from USD 1.2 billion in 2024-e at a CAGR of 10.1% to touch USD 2.4 billion by 2030. The Vaginal Fungi Infections Treatment Market is dominated by key players such as Pfizer Inc., Johnson & Johnson Services, Inc., Novartis International AG, Merck & Co., Inc., GlaxoSmithKline plc, Abbott Laboratories, Sanofi S.A., Bayer AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Actavis Generics.